New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
08:45 EDTGTHPGuided Therapeutics announces presentation of LuViva study
LuViva, a non-invasive device used to detect cervical disease instantly at the point of care, is a product of Guided Therapeutics. The LuViva Advanced Cervical Scan identified 100% of all cervical disease cases in a blinded clinical study presented at the International Federation for Cervical Pathology and Colposcopy meeting in London. LuViva also correctly identified 44% of women who had a previous abnormal Pap test and who were determined to be false positives as part of the study. According to the conclusions of the study, the high sensitivity, specificity and resulting high negative predictive value of LuViva imply that nearly half of the women currently undergoing colposcopy and biopsy could safely avoid those procedures, thereby improving clinic efficiency and resulting in significant savings to health care systems.
News For GTHP From The Last 14 Days
Check below for free stories on GTHP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
08:07 EDTGTHPGuided Therapeutics files PMA amendment with FDA for LuViva Scan
Subscribe for More Information
July 17, 2014
08:08 EDTGTHPGuided Therapeutics awarded additional patent for LuViva
Guided Therapeutics announced that U.S. Patent and Trademark Office granted a new patent with 22 claims that support the technology behind the LuViva Advanced Cervical Scan. Patent number 8,781,560 B2 entitled “Method and Apparatus for Rapid Detection and Diagnosis of Tissue Abnormalities” covers the use of two types of spectroscopy in conjunction with images of tissue to detect abnormalities in tissue. Most importantly, the inventions described in the patent function as an additional bridge from theoretical models of tissue spectroscopy to a fully functional, commercially viable cancer detection system that can be utilized as a platform for many types of epithelial cancers.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use